Template:Infobox drug/testcases

Infobox drug development (Drugbox - talk central, overview, sandboxes, testcases) WT:PHARM

/sandbox: {{Drugbox}} · {{title}} ·  · src {{licence}} ·  · src {{legal}} ·  · src {{pregcat}} ·  · src {{molarmass}} ·  · src {{mab source}} ·  · src {{localINNvar}} ·  · src {{maint cat}} ·  · src {{fmtATC}} ·  · src /format · Infobox drug/sandbox (edit · t · history · diff · links · /test · Source · e · t · hist · links · /subpages · /doc · /doc edit) FDA-2023 {{Infobox drug/doc/FDA-2023}} · /testcases-FDA -- 2023  · /sandbox2 parameters Full parameter list () · Type-conditional sections TPU cats:Category:Infobox drug tracking categories (32): Category:Pages using infobox drug with unknown parameters (9) · Parameter usage report cat:IBdrug templates · cat:Templates used in IBdrug testcases (m view): Template:Infobox drug/testcases -- General /testcases2 -- titles, licence, EMA /testcases3 -- pregcat, legal, licence, PLLR, ATC; Wikidata /testcases4 -- chem formula, mab /testcases5 -- identifiers, second id's /testcases6 -- all up /testcases7images -- images /testcases8 -- type, titles /testcases9 -- order variants, container_only /testcases10 -- pharmacokinetic, localINN (2017) has (data page) -- is a redirect /testcases11 -- hormone, gene therapy (2018), has (data page) /testcases-FDA -- FDA 2023 /testcases-warning -- warning box(es) RC recent changes Chem+Drugbox templates · Drugbox transclusions Module:TemplatePar bot Settings.css · Settings/sandbox · {{cascite}} chembox {{Chem/dev/nav}} · {{Chembox}} Infobox drug class/sandbox (edit · t · history · diff · links · /test · Source · e · t · hist · links · /subpages · /doc · /doc edit)

biosimilars

eg Rituximab

Side by side comparison

{{Infobox drug}}	{{Infobox drug/sandbox}}
Infobox drug/testcases Clinical data Other names synonyms Biosimilars rituximab-abbs, rituximab-pvvr, rituximab-arrx AHFS/Drugs.com Monograph	Infobox drug/testcases Clinical data Other names synonyms Biosimilars rituximab-abbs, rituximab-pvvr, rituximab-arrx AHFS/Drugs.com Monograph

References

Test Brazilian Legal Status

Side by side comparison

{{Infobox drug}}	{{Infobox drug/sandbox}}
Infobox drug/testcases Legal status Legal status AU: S2 (Pharmacy medicine) BR: Class A1 (Narcotic drugs) CA: Schedule I DE: Anlage I (Authorized scientific use only) UK: General sales list (GSL, OTC) US: ℞-only	Infobox drug/testcases Legal status Legal status AU: S2 (Pharmacy medicine) BR: Class A1 (Narcotic drugs) CA: Schedule I DE: Anlage I (Authorized scientific use only) UK: General sales list (GSL, OTC) US: ℞-only

Test 0 = blanks

Side by side comparison

{{Infobox drug}}	{{Infobox drug/sandbox}}
Infobox drug/testcases	Infobox drug/testcases

Test 1

Side by side comparison

{{Infobox drug}}

{{Infobox drug/sandbox}}

Infobox drug/testcases INN: Linezolid Clinical data Pronunciation /njuːˈmoʊniə/ Trade names Linospan, Zyvox, Zyvoxam, Zyvoxid Other names Lenzomore AHFS/Drugs.com Monograph MedlinePlus a602004 License data EU EMA: by INN US DailyMed: Linezolid US FDA: Linezolid Pregnancy category AU: C Dependence liability High Addiction liability Low Routes of administration Intravenous infusion, oral ATC code J01XX08 (WHO) Pharmacokinetic data Bioavailability ~100% (oral) Protein binding Low (31%) Metabolism Hepatic (50–70%, CYP not involved) Metabolites some stuff Onset of action 1 hr Elimination half-life 4.2–5.4 hours (shorter in children) Duration of action 1 to 3 hr Excretion Nonrenal, renal, and fecal Identifiers IUPAC name (S)-N-({3-[3-fluoro-4-(morpholin-4-yl)phenyl]-2-oxo-1,3-oxazolidin-5-yl}methyl)acetamide CAS Number 165800-03-3 Y PubChem CID 441401 IUPHAR/BPS 1234 DrugBank DB00601 UNII ISQ9I6J12J KEGG D00947 Y ChEMBL ChEMBL126 Y NIAID ChemDB 070944 PDB ligand ZLD (PDBe, RCSB PDB) Chemical and physical data Formula C16H20FN3O4 Molar mass 337.346 g/mol g·mol−1 3D model (JSmol) Interactive image Density 1.40 g/cm3 Melting point 135 °C (275 °F) Boiling point 140 °C (284 °F) (decomposes) Solubility in water 3 mg/mL (20 °C) SMILES O=C1O[C@@H](CNC(=O)C)CN1c3cc(F)c(N2CCOCC2)cc3 InChI InChI=1S/C16H20FN3O4/c1-11(21)18-9-13-10-20(16(22)24-13)12-2-3-15(14(17)8-12)19-4-6-23-7-5-19/h2-3,8,13H,4-7,9-10H2,1H3,(H,18,21)/t13-/m0/s1 Y Key:TYZROVQLWOKYKF-ZDUSSCGKSA-N Y  NY (what is this?)  (verify)

Infobox drug/testcases INN: Linezolid Clinical data Pronunciation /njuːˈmoʊniə/ Trade names Linospan, Zyvox, Zyvoxam, Zyvoxid Other names Lenzomore AHFS/Drugs.com Monograph MedlinePlus a602004 License data EU EMA: by INN US DailyMed: Linezolid US FDA: Linezolid Pregnancy category AU: C Dependence liability High Addiction liability Low Routes of administration Intravenous infusion, oral ATC code J01XX08 (WHO) Pharmacokinetic data Bioavailability ~100% (oral) Protein binding Low (31%) Metabolism Hepatic (50–70%, CYP not involved) Metabolites some stuff Onset of action 1 hr Elimination half-life 4.2–5.4 hours (shorter in children) Duration of action 1 to 3 hr Excretion Nonrenal, renal, and fecal Identifiers IUPAC name (S)-N-({3-[3-fluoro-4-(morpholin-4-yl)phenyl]-2-oxo-1,3-oxazolidin-5-yl}methyl)acetamide CAS Number 165800-03-3 Y PubChem CID 441401 IUPHAR/BPS 1234 DrugBank DB00601 UNII ISQ9I6J12J KEGG D00947 Y ChEMBL ChEMBL126 Y NIAID ChemDB 070944 PDB ligand ZLD (PDBe, RCSB PDB) Chemical and physical data Formula C16H20FN3O4 Molar mass 337.346 g/mol g·mol−1 3D model (JSmol) Interactive image Density 1.40 g/cm3 Melting point 135 °C (275 °F) Boiling point 140 °C (284 °F) (decomposes) Solubility in water 3 mg/mL (20 °C) SMILES O=C1O[C@@H](CNC(=O)C)CN1c3cc(F)c(N2CCOCC2)cc3 InChI InChI=1S/C16H20FN3O4/c1-11(21)18-9-13-10-20(16(22)24-13)12-2-3-15(14(17)8-12)19-4-6-23-7-5-19/h2-3,8,13H,4-7,9-10H2,1H3,(H,18,21)/t13-/m0/s1 Y Key:TYZROVQLWOKYKF-ZDUSSCGKSA-N Y  NY (what is this?)  (verify)

Test 2

Side by side comparison

{{Infobox drug}}

{{Infobox drug/sandbox}}

Infobox drug/testcases Clinical data Pronunciation /njuːˈmoʊniə/ Other names 3{[(4-cyclopentyl-1-piperazinyl)imino]methyl}rifamycin AHFS/Drugs.com Monograph MedlinePlus a602026 ATC code J04AB05 (WHO) Pharmacokinetic data Bioavailability increases when administered with food Onset of action 1 hr Identifiers IUPAC name (7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z,26E)-26-{[(4-cyclopentylpiperazin-1-yl)amino]methylidene}-2,15,17,29-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23,27-trioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(28),2,4,9,19,21,25(29)-heptaen-13-yl acetate CAS Number 61379-65-5 PubChem CID 5462354 DrugBank APRD01217 ChemSpider 10482075 Y UNII XJM390A33U KEGG D00879 N ChEBI CHEBI:45304 N ChEMBL ChEMBL1660 N NIAID ChemDB 007686 Chemical and physical data Formula C47H64N4O12 Molar mass 877.031 g/mol g·mol−1 3D model (JSmol) Interactive image SMILES CC(=O)O[C@H]3[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)\C=C\C=C(\C)C(=O)Nc6c(/C=N/N1CCN(CC1)C2CCCC2)c(O)c5c4C(=O)[C@@](C)(O/C=C/[C@H](OC)[C@H]3C)Oc4c(C)c(O)c5c6O InChI InChI=1S/C47H64N4O12/c1-24-13-12-14-25(2)46(59)49-37-32(23-48-51-20-18-50(19-21-51)31-15-10-11-16-31)41(56)34-35(42(37)57)40(55)29(6)44-36(34)45(58)47(8,63-44)61-22-17-33(60-9)26(3)43(62-30(7)52)28(5)39(54)27(4)38(24)53/h12-14,17,22-24,26-28,31,33,38-39,43,53-57H,10-11,15-16,18-21H2,1-9H3,(H,49,59)/b13-12+,22-17+,25-14-,48-23+/t24-,26+,27+,28+,33-,38-,39+,43+,47-/m0/s1 Y Commenting here Key:WDZCUPBHRAEYDL-GZAUEHORSA-N Y  NY (what is this?)  (verify)

Infobox drug/testcases Clinical data Pronunciation /njuːˈmoʊniə/ Other names 3{[(4-cyclopentyl-1-piperazinyl)imino]methyl}rifamycin AHFS/Drugs.com Monograph MedlinePlus a602026 ATC code J04AB05 (WHO) Pharmacokinetic data Bioavailability increases when administered with food Onset of action 1 hr Identifiers IUPAC name (7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z,26E)-26-{[(4-cyclopentylpiperazin-1-yl)amino]methylidene}-2,15,17,29-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23,27-trioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(28),2,4,9,19,21,25(29)-heptaen-13-yl acetate CAS Number 61379-65-5 PubChem CID 5462354 DrugBank APRD01217 ChemSpider 10482075 Y UNII XJM390A33U KEGG D00879 N ChEBI CHEBI:45304 N ChEMBL ChEMBL1660 N NIAID ChemDB 007686 Chemical and physical data Formula C47H64N4O12 Molar mass 877.031 g/mol g·mol−1 3D model (JSmol) Interactive image SMILES CC(=O)O[C@H]3[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)\C=C\C=C(\C)C(=O)Nc6c(/C=N/N1CCN(CC1)C2CCCC2)c(O)c5c4C(=O)[C@@](C)(O/C=C/[C@H](OC)[C@H]3C)Oc4c(C)c(O)c5c6O InChI InChI=1S/C47H64N4O12/c1-24-13-12-14-25(2)46(59)49-37-32(23-48-51-20-18-50(19-21-51)31-15-10-11-16-31)41(56)34-35(42(37)57)40(55)29(6)44-36(34)45(58)47(8,63-44)61-22-17-33(60-9)26(3)43(62-30(7)52)28(5)39(54)27(4)38(24)53/h12-14,17,22-24,26-28,31,33,38-39,43,53-57H,10-11,15-16,18-21H2,1-9H3,(H,49,59)/b13-12+,22-17+,25-14-,48-23+/t24-,26+,27+,28+,33-,38-,39+,43+,47-/m0/s1 Y Commenting here Key:WDZCUPBHRAEYDL-GZAUEHORSA-N Y  NY (what is this?)  (verify)

References

Test 3

Side by side comparison

{{Infobox drug}}	{{Infobox drug/sandbox}}
Infobox drug/testcases Vaccine description Target Tuberculosis Vaccine type Live bacteria Clinical data Pronunciation /njuːˈmoʊniə/ AHFS/Drugs.com FDA Professional Drug Information Routes of administration Percutaneous ATC code J07AN01 (WHO) Legal status Legal status US: ℞-only Identifiers ChemSpider NA	Infobox drug/testcases Vaccine description Target Tuberculosis Vaccine type Live bacteria Clinical data Pronunciation /njuːˈmoʊniə/ AHFS/Drugs.com FDA Professional Drug Information Routes of administration Percutaneous ATC code J07AN01 (WHO) Legal status Legal status US: ℞-only Identifiers ChemSpider NA

Test 4

Side by side comparison

{{Infobox drug}}

{{Infobox drug/sandbox}}

Infobox drug/testcases Clinical data Pronunciation /njuːˈmoʊniə/ Trade names Lipitor, Atorva AHFS/Drugs.com Monograph MedlinePlus a600045 License data US DailyMed: 42465 US FDA: Atorvastatin Pregnancy category AU: D Routes of administration Oral ATC code C10AA05 (WHO) Legal status Legal status AU: S4 (Prescription only) UK: POM (Prescription only) US: ℞-only Pharmacokinetic data Bioavailability 12% Metabolism Hepatic - CYP3A4 Onset of action 1 hr Elimination half-life 14 h Excretion Bile Identifiers IUPAC name (3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoic acid CAS Number 134523-00-5 Y PubChem CID 60823 IUPHAR/BPS 2949 DrugBank APRD00055 N ChemSpider 54810 Y UNII A0JWA85V8F KEGG D07474 Y ChEBI CHEBI:39548 Y ChEMBL ChEMBL1487 Y PDB ligand 117 (PDBe, RCSB PDB) Chemical and physical data Formula C33H35Ca2FN2O5 Molar mass 558.64 g·mol−1 3D model (JSmol) Interactive image SMILES O=C(O)C[C@H](O)C[C@H](O)CCn2c(c(c(c2c1ccc(F)cc1)c3ccccc3)C(=O)Nc4ccccc4)C(C)C InChI InChI=1S/C33H35FN2O5/c1-21(2)31-30(33(41)35-25-11-7-4-8-12-25)29(22-9-5-3-6-10-22)32(23-13-15-24(34)16-14-23)36(31)18-17-26(37)19-27(38)20-28(39)40/h3-16,21,26-27,37-38H,17-20H2,1-2H3,(H,35,41)(H,39,40)/t26-,27-/m1/s1 Y Key:XUKUURHRXDUEBC-KAYWLYCHSA-N Y  NY (what is this?)  (verify)

Infobox drug/testcases Clinical data Pronunciation /njuːˈmoʊniə/ Trade names Lipitor, Atorva AHFS/Drugs.com Monograph MedlinePlus a600045 License data US DailyMed: 42465 US FDA: Atorvastatin Pregnancy category AU: D Routes of administration Oral ATC code C10AA05 (WHO) Legal status Legal status AU: S4 (Prescription only) UK: POM (Prescription only) US: ℞-only Pharmacokinetic data Bioavailability 12% Metabolism Hepatic - CYP3A4 Onset of action 1 hr Elimination half-life 14 h Excretion Bile Identifiers IUPAC name (3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoic acid CAS Number 134523-00-5 Y PubChem CID 60823 IUPHAR/BPS 2949 DrugBank APRD00055 N ChemSpider 54810 Y UNII A0JWA85V8F KEGG D07474 Y ChEBI CHEBI:39548 Y ChEMBL ChEMBL1487 Y PDB ligand 117 (PDBe, RCSB PDB) Chemical and physical data Formula C33H35Ca2FN2O5 Molar mass 558.64 g·mol−1 3D model (JSmol) Interactive image SMILES O=C(O)C[C@H](O)C[C@H](O)CCn2c(c(c(c2c1ccc(F)cc1)c3ccccc3)C(=O)Nc4ccccc4)C(C)C InChI InChI=1S/C33H35FN2O5/c1-21(2)31-30(33(41)35-25-11-7-4-8-12-25)29(22-9-5-3-6-10-22)32(23-13-15-24(34)16-14-23)36(31)18-17-26(37)19-27(38)20-28(39)40/h3-16,21,26-27,37-38H,17-20H2,1-2H3,(H,35,41)(H,39,40)/t26-,27-/m1/s1 Y Key:XUKUURHRXDUEBC-KAYWLYCHSA-N Y  NY (what is this?)  (verify)

Test all 1

Side by side comparison

{{Infobox drug}}

{{Infobox drug/sandbox}}

1 some images Clinical data Pronunciation /njuːˈmoʊniə/ Trade names 25 Other names 72 AHFS/Drugs.com 27 MedlinePlus 29 License data EU EMA: by INN US DailyMed: 32 US FDA: 31 Pregnancy category AU: B3 35 Dependence liability 43 Routes of administration 44 ATC code 5455 (WHO) 56 Legal status Legal status AU: S4 (Prescription only) CA: Schedule IV UK: POM (Prescription only) US: Schedule III UN: Narcotic Schedules II and III EU: Category 2 Precursor In general: ℞ (Prescription only) Pharmacokinetic data Bioavailability 45 Protein binding 46 Metabolism 47 Onset of action 47.5 Elimination half-life 48 Excretion 49 Identifiers IUPAC name 12 CAS Number 5051 52 PubChem CID 57 PubChem SID 58 IUPHAR/BPS 59 DrugBank 60 ChemSpider 6162 UNII 63 KEGG 6566 ChEBI CHEBI:6768 ChEMBL ChEMBL6970 NIAID ChemDB 71 PDB ligand 73 (PDBe, RCSB PDB) Chemical and physical data Formula 74 Molar mass 75 g·mol−1 3D model (JSmol) Interactive image Specific rotation 90 Density 83 g/cm3 note83 Melting point 84 to 85 °C (183 to 185 °F) 86 Boiling point 87 °C (189 °F) 88 Solubility in water 89 mg/mL (20 °C) SMILES 76 InChI InChI=7779 78 Key:8082   (verify)

1 some images Clinical data Pronunciation /njuːˈmoʊniə/ Trade names 25 Other names 72 AHFS/Drugs.com 27 MedlinePlus 29 License data EU EMA: by INN US DailyMed: 32 US FDA: 31 Pregnancy category AU: B3 35 Dependence liability 43 Routes of administration 44 ATC code 5455 (WHO) 56 Legal status Legal status AU: S4 (Prescription only) CA: Schedule IV UK: POM (Prescription only) US: Schedule III UN: Narcotic Schedules II and III EU: Category 2 Precursor In general: ℞ (Prescription only) Pharmacokinetic data Bioavailability 45 Protein binding 46 Metabolism 47 Onset of action 47.5 Elimination half-life 48 Excretion 49 Identifiers IUPAC name 12 CAS Number 5051 52 PubChem CID 57 PubChem SID 58 IUPHAR/BPS 59 DrugBank 60 ChemSpider 6162 UNII 63 KEGG 6566 ChEBI CHEBI:6768 ChEMBL ChEMBL6970 NIAID ChemDB 71 PDB ligand 73 (PDBe, RCSB PDB) Chemical and physical data Formula 74 Molar mass 75 g·mol−1 3D model (JSmol) Interactive image Specific rotation 90 Density 83 g/cm3 note83 Melting point 84 to 85 °C (183 to 185 °F) 86 Boiling point 87 °C (189 °F) 88 Solubility in water 89 mg/mL (20 °C) SMILES 76 InChI InChI=7779 78 Key:8082   (verify)

Test all 2

Side by side comparison

{{Infobox drug}}

{{Infobox drug/sandbox}}

1 some images Combination of 17 18 19 20 21 22 23 24 Clinical data Pronunciation /njuːˈmoʊniə/ Trade names 25 Other names 72 AHFS/Drugs.com 27 MedlinePlus 29 License data EU EMA: by INN US DailyMed: 32 US FDA: 31 Pregnancy category AU: B3 35 Dependence liability 43 Routes of administration 44 ATC code 5455 (WHO) 56 Legal status Legal status AU: S4 (Prescription only) CA: Schedule IV UK: POM (Prescription only) US: Schedule III UN: Narcotic Schedules II and III EU: Category 2 Precursor In general: ℞ (Prescription only) Pharmacokinetic data Bioavailability 45 Protein binding 46 Metabolism 47 Onset of action 47.5 Elimination half-life 48 Excretion 49 Identifiers CAS Number 5051 52 PubChem CID 57 PubChem SID 58 IUPHAR/BPS 59 DrugBank 60 ChemSpider 6162 UNII 63 KEGG 6566 ChEBI CHEBI:6768 ChEMBL ChEMBL6970 NIAID ChemDB 71 Chemical and physical data Formula 74 Molar mass 75 g·mol−1 3D model (JSmol) Interactive image Specific rotation 90 Density 83 g/cm3 Melting point 84 to 85 °C (183 to 185 °F) 86 Boiling point 87 °C (189 °F) 88 Solubility in water 89 mg/mL (20 °C) SMILES 76 InChI InChI=7779 78 Key:8082   (verify)

1 some images Combination of 17 18 19 20 21 22 23 24 Clinical data Pronunciation /njuːˈmoʊniə/ Trade names 25 Other names 72 AHFS/Drugs.com 27 MedlinePlus 29 License data EU EMA: by INN US DailyMed: 32 US FDA: 31 Pregnancy category AU: B3 35 Dependence liability 43 Routes of administration 44 ATC code 5455 (WHO) 56 Legal status Legal status AU: S4 (Prescription only) CA: Schedule IV UK: POM (Prescription only) US: Schedule III UN: Narcotic Schedules II and III EU: Category 2 Precursor In general: ℞ (Prescription only) Pharmacokinetic data Bioavailability 45 Protein binding 46 Metabolism 47 Onset of action 47.5 Elimination half-life 48 Excretion 49 Identifiers CAS Number 5051 52 PubChem CID 57 PubChem SID 58 IUPHAR/BPS 59 DrugBank 60 ChemSpider 6162 UNII 63 KEGG 6566 ChEBI CHEBI:6768 ChEMBL ChEMBL6970 NIAID ChemDB 71 Chemical and physical data Formula 74 Molar mass 75 g·mol−1 3D model (JSmol) Interactive image Specific rotation 90 Density 83 g/cm3 Melting point 84 to 85 °C (183 to 185 °F) 86 Boiling point 87 °C (189 °F) 88 Solubility in water 89 mg/mL (20 °C) SMILES 76 InChI InChI=7779 78 Key:8082   (verify)

Test all 3

Side by side comparison

{{Infobox drug}}

{{Infobox drug/sandbox}}

1 some images Vaccine description Target 13 Vaccine type Toxoid Clinical data Pronunciation /njuːˈmoʊniə/ Trade names 25 Other names 72 AHFS/Drugs.com 27 MedlinePlus 29 License data EU EMA: by INN US DailyMed: 32 US FDA: 31 Pregnancy category AU: B3 35 Dependence liability 43 Routes of administration 44 ATC code 5455 (WHO) 56 Legal status Legal status AU: S4 (Prescription only) CA: Schedule IV UK: POM (Prescription only) US: Schedule III UN: Narcotic Schedules II and III EU: Category 2 Precursor In general: ℞ (Prescription only) Pharmacokinetic data Bioavailability 45 Protein binding 46 Metabolism 47 Onset of action 47.5 Elimination half-life 48 Excretion 49 Identifiers CAS Number 5051 52 PubChem CID 57 PubChem SID 58 IUPHAR/BPS 59 DrugBank 60 ChemSpider 6162 UNII 63 KEGG 6566 ChEBI CHEBI:6768 ChEMBL ChEMBL6970 NIAID ChemDB 71 Chemical and physical data Formula 74 Molar mass 75 g·mol−1 3D model (JSmol) Interactive image Specific rotation 90 Density 83 g/cm3 Melting point 84 to 85 °C (183 to 185 °F) 86 Boiling point 87 °C (189 °F) 88 Solubility in water 89 mg/mL (20 °C) SMILES 76 InChI InChI=7779 78 Key:8082   (verify)

1 some images Vaccine description Target 13 Vaccine type Toxoid Clinical data Pronunciation /njuːˈmoʊniə/ Trade names 25 Other names 72 AHFS/Drugs.com 27 MedlinePlus 29 License data EU EMA: by INN US DailyMed: 32 US FDA: 31 Pregnancy category AU: B3 35 Dependence liability 43 Routes of administration 44 ATC code 5455 (WHO) 56 Legal status Legal status AU: S4 (Prescription only) CA: Schedule IV UK: POM (Prescription only) US: Schedule III UN: Narcotic Schedules II and III EU: Category 2 Precursor In general: ℞ (Prescription only) Pharmacokinetic data Bioavailability 45 Protein binding 46 Metabolism 47 Onset of action 47.5 Elimination half-life 48 Excretion 49 Identifiers CAS Number 5051 52 PubChem CID 57 PubChem SID 58 IUPHAR/BPS 59 DrugBank 60 ChemSpider 6162 UNII 63 KEGG 6566 ChEBI CHEBI:6768 ChEMBL ChEMBL6970 NIAID ChemDB 71 Chemical and physical data Formula 74 Molar mass 75 g·mol−1 3D model (JSmol) Interactive image Specific rotation 90 Density 83 g/cm3 Melting point 84 to 85 °C (183 to 185 °F) 86 Boiling point 87 °C (189 °F) 88 Solubility in water 89 mg/mL (20 °C) SMILES 76 InChI InChI=7779 78 Key:8082   (verify)

Test all 4

Side by side comparison

{{Infobox drug}}

{{Infobox drug/sandbox}}

1 some images Monoclonal antibody Type F(ab')2 fragment Source Chimeric (rat/human) Target 13 Clinical data Pronunciation /njuːˈmoʊniə/ Trade names 25 Other names 72 AHFS/Drugs.com 27 MedlinePlus 29 License data EU EMA: by INN US DailyMed: 32 US FDA: 31 Pregnancy category AU: B3 35 Dependence liability 43 Addiction liability 43b Routes of administration 44 ATC code 5455 (WHO) 56 Legal status Legal status AU: S4 (Prescription only) CA: Schedule IV UK: POM (Prescription only) US: Schedule III UN: Narcotic Schedules II and III EU: Category 2 Precursor In general: ℞ (Prescription only) Pharmacokinetic data Bioavailability 45 Protein binding 46 Metabolism 47 Onset of action 47.5 Elimination half-life 48 Excretion 49 Identifiers CAS Number 5051 52 PubChem CID 57 PubChem SID 58 IUPHAR/BPS 59 DrugBank 60 ChemSpider 6162 UNII 63 KEGG 6566 ChEBI CHEBI:6768 ChEMBL ChEMBL6970 NIAID ChemDB 71 PDB ligand 73 (PDBe, RCSB PDB) Chemical and physical data Formula 74 Molar mass 75 g·mol−1 3D model (JSmol) Interactive image Specific rotation 90 Density 83 g/cm3 Melting point 84 to 85 °C (183 to 185 °F) 86 Boiling point 87 °C (189 °F) 88 Solubility in water 89 mg/mL (20 °C) SMILES 76 InChI InChI=7779 78 Key:8082   (verify)

1 some images Monoclonal antibody Type F(ab')2 fragment Source Chimeric (rat/human) Target 13 Clinical data Pronunciation /njuːˈmoʊniə/ Trade names 25 Other names 72 AHFS/Drugs.com 27 MedlinePlus 29 License data EU EMA: by INN US DailyMed: 32 US FDA: 31 Pregnancy category AU: B3 35 Dependence liability 43 Addiction liability 43b Routes of administration 44 ATC code 5455 (WHO) 56 Legal status Legal status AU: S4 (Prescription only) CA: Schedule IV UK: POM (Prescription only) US: Schedule III UN: Narcotic Schedules II and III EU: Category 2 Precursor In general: ℞ (Prescription only) Pharmacokinetic data Bioavailability 45 Protein binding 46 Metabolism 47 Onset of action 47.5 Elimination half-life 48 Excretion 49 Identifiers CAS Number 5051 52 PubChem CID 57 PubChem SID 58 IUPHAR/BPS 59 DrugBank 60 ChemSpider 6162 UNII 63 KEGG 6566 ChEBI CHEBI:6768 ChEMBL ChEMBL6970 NIAID ChemDB 71 PDB ligand 73 (PDBe, RCSB PDB) Chemical and physical data Formula 74 Molar mass 75 g·mol−1 3D model (JSmol) Interactive image Specific rotation 90 Density 83 g/cm3 Melting point 84 to 85 °C (183 to 185 °F) 86 Boiling point 87 °C (189 °F) 88 Solubility in water 89 mg/mL (20 °C) SMILES 76 InChI InChI=7779 78 Key:8082   (verify)

Test formula 1

Side by side comparison

{{Infobox drug}}

{{Infobox drug/sandbox}}

1 some images Clinical data Pronunciation /njuːˈmoʊniə/ Trade names 25 Other names 72 AHFS/Drugs.com 27 MedlinePlus 29 License data EU EMA: by INN US DailyMed: 32 US FDA: 31 Pregnancy category AU: B3 35 Dependence liability 43 Routes of administration 44 ATC code 5455 (WHO) 56 Legal status Legal status AU: S4 (Prescription only) CA: Schedule IV UK: POM (Prescription only) US: Schedule III UN: Narcotic Schedules II and III EU: Category 2 Precursor In general: ℞ (Prescription only) Pharmacokinetic data Bioavailability 45 Protein binding 46 Metabolism 47 Onset of action 47.5 Elimination half-life 48 Excretion 49 Identifiers IUPAC name 12 CAS Number 5051 52 PubChem CID 57 PubChem SID 58 IUPHAR/BPS 59 DrugBank 60 ChemSpider 6162 UNII 63 KEGG 6566 ChEBI CHEBI:6768 ChEMBL ChEMBL6970 NIAID ChemDB 71 PDB ligand 73 (PDBe, RCSB PDB) Chemical and physical data Formula CH2Ag3Al4As5Au6B7Bi8−1 Molar mass 75 g·mol−1 3D model (JSmol) Interactive image Specific rotation 90 Density 83 g/cm3 Melting point 84 to 85 °C (183 to 185 °F) 86 Boiling point 87 °C (189 °F) 88 Solubility in water 89 mg/mL (20 °C) SMILES 76 InChI InChI=7779 78 Key:8082   (verify)

1 some images Clinical data Pronunciation /njuːˈmoʊniə/ Trade names 25 Other names 72 AHFS/Drugs.com 27 MedlinePlus 29 License data EU EMA: by INN US DailyMed: 32 US FDA: 31 Pregnancy category AU: B3 35 Dependence liability 43 Routes of administration 44 ATC code 5455 (WHO) 56 Legal status Legal status AU: S4 (Prescription only) CA: Schedule IV UK: POM (Prescription only) US: Schedule III UN: Narcotic Schedules II and III EU: Category 2 Precursor In general: ℞ (Prescription only) Pharmacokinetic data Bioavailability 45 Protein binding 46 Metabolism 47 Onset of action 47.5 Elimination half-life 48 Excretion 49 Identifiers IUPAC name 12 CAS Number 5051 52 PubChem CID 57 PubChem SID 58 IUPHAR/BPS 59 DrugBank 60 ChemSpider 6162 UNII 63 KEGG 6566 ChEBI CHEBI:6768 ChEMBL ChEMBL6970 NIAID ChemDB 71 PDB ligand 73 (PDBe, RCSB PDB) Chemical and physical data Formula CH2Ag3Al4As5Au6B7Bi8−1 Molar mass 75 g·mol−1 3D model (JSmol) Interactive image Specific rotation 90 Density 83 g/cm3 Melting point 84 to 85 °C (183 to 185 °F) 86 Boiling point 87 °C (189 °F) 88 Solubility in water 89 mg/mL (20 °C) SMILES 76 InChI InChI=7779 78 Key:8082   (verify)

Test formula 2

Side by side comparison

{{Infobox drug}}

{{Infobox drug/sandbox}}

1 some images Clinical data Pronunciation /njuːˈmoʊniə/ Trade names 25 Other names 72 AHFS/Drugs.com 27 MedlinePlus 29 License data EU EMA: by INN US DailyMed: 32 US FDA: 31 Pregnancy category AU: B3 35 Dependence liability 43 Routes of administration 44 ATC code 5455 (WHO) 56 Legal status Legal status AU: S4 (Prescription only) CA: Schedule IV UK: POM (Prescription only) US: Schedule III UN: Narcotic Schedules II and III EU: Category 2 Precursor In general: ℞ (Prescription only) Pharmacokinetic data Bioavailability 45 Protein binding 46 Metabolism 47 Onset of action 47.5 Elimination half-life 48 Excretion 49 Identifiers IUPAC name 12 CAS Number 5051 52 PubChem CID 57 PubChem SID 58 IUPHAR/BPS 59 DrugBank 60 ChemSpider 6162 UNII 63 KEGG 6566 ChEBI CHEBI:6768 ChEMBL ChEMBL6970 NIAID ChemDB 71 PDB ligand 73 (PDBe, RCSB PDB) Chemical and physical data Formula CBr9Ca10Cl11Co12Cr13F14Fe15Gd16Hg17−1 Molar mass 75 g·mol−1 3D model (JSmol) Interactive image Specific rotation 90 Density note83 Melting point 84 to 85 °C (183 to 185 °F) 86 Boiling point 87 °C (189 °F) 88 Solubility in water 89 mg/mL (20 °C) SMILES 76 InChI InChI=7779 78 Key:8082   (verify)

1 some images Clinical data Pronunciation /njuːˈmoʊniə/ Trade names 25 Other names 72 AHFS/Drugs.com 27 MedlinePlus 29 License data EU EMA: by INN US DailyMed: 32 US FDA: 31 Pregnancy category AU: B3 35 Dependence liability 43 Routes of administration 44 ATC code 5455 (WHO) 56 Legal status Legal status AU: S4 (Prescription only) CA: Schedule IV UK: POM (Prescription only) US: Schedule III UN: Narcotic Schedules II and III EU: Category 2 Precursor In general: ℞ (Prescription only) Pharmacokinetic data Bioavailability 45 Protein binding 46 Metabolism 47 Onset of action 47.5 Elimination half-life 48 Excretion 49 Identifiers IUPAC name 12 CAS Number 5051 52 PubChem CID 57 PubChem SID 58 IUPHAR/BPS 59 DrugBank 60 ChemSpider 6162 UNII 63 KEGG 6566 ChEBI CHEBI:6768 ChEMBL ChEMBL6970 NIAID ChemDB 71 PDB ligand 73 (PDBe, RCSB PDB) Chemical and physical data Formula CBr9Ca10Cl11Co12Cr13F14Fe15Gd16Hg17−1 Molar mass 75 g·mol−1 3D model (JSmol) Interactive image Specific rotation 90 Density note83 Melting point 84 to 85 °C (183 to 185 °F) 86 Boiling point 87 °C (189 °F) 88 Solubility in water 89 mg/mL (20 °C) SMILES 76 InChI InChI=7779 78 Key:8082   (verify)

Test formula 3

Side by side comparison

{{Infobox drug}}

{{Infobox drug/sandbox}}

1 some images Clinical data Pronunciation /njuːˈmoʊniə/ Trade names 25 Other names 72 AHFS/Drugs.com 27 MedlinePlus 29 License data EU EMA: by INN US DailyMed: 32 US FDA: 31 Pregnancy category AU: B3 35 Dependence liability 43 Routes of administration 44 ATC code 5455 (WHO) 56 Legal status Legal status AU: S4 (Prescription only) CA: Schedule IV UK: POM (Prescription only) US: Schedule III UN: Narcotic Schedules II and III EU: Category 2 Precursor In general: ℞ (Prescription only) Pharmacokinetic data Bioavailability 45 Protein binding 46 Metabolism 47 Onset of action 47.5 Elimination half-life 48 Excretion 49 Identifiers IUPAC name 12 CAS Number 5051 52 PubChem CID 57 PubChem SID 58 IUPHAR/BPS 59 DrugBank 60 ChemSpider 6162 UNII 63 KEGG 6566 ChEBI CHEBI:6768 ChEMBL ChEMBL6970 NIAID ChemDB 71 PDB ligand 73 (PDBe, RCSB PDB) Chemical and physical data Formula I18K19Li20Mg21Mn22N23Na24O25P26Pt27−1 Molar mass 75 g·mol−1 3D model (JSmol) Interactive image Specific rotation 90 Density 83 g/cm3 Melting point 84 to 85 °C (183 to 185 °F) 86 Boiling point 87 °C (189 °F) 88 Solubility in water 89 mg/mL (20 °C) SMILES 76 InChI InChI=7779 78 Key:8082   (verify)

1 some images Clinical data Pronunciation /njuːˈmoʊniə/ Trade names 25 Other names 72 AHFS/Drugs.com 27 MedlinePlus 29 License data EU EMA: by INN US DailyMed: 32 US FDA: 31 Pregnancy category AU: B3 35 Dependence liability 43 Routes of administration 44 ATC code 5455 (WHO) 56 Legal status Legal status AU: S4 (Prescription only) CA: Schedule IV UK: POM (Prescription only) US: Schedule III UN: Narcotic Schedules II and III EU: Category 2 Precursor In general: ℞ (Prescription only) Pharmacokinetic data Bioavailability 45 Protein binding 46 Metabolism 47 Onset of action 47.5 Elimination half-life 48 Excretion 49 Identifiers IUPAC name 12 CAS Number 5051 52 PubChem CID 57 PubChem SID 58 IUPHAR/BPS 59 DrugBank 60 ChemSpider 6162 UNII 63 KEGG 6566 ChEBI CHEBI:6768 ChEMBL ChEMBL6970 NIAID ChemDB 71 PDB ligand 73 (PDBe, RCSB PDB) Chemical and physical data Formula I18K19Li20Mg21Mn22N23Na24O25P26Pt27−1 Molar mass 75 g·mol−1 3D model (JSmol) Interactive image Specific rotation 90 Density 83 g/cm3 Melting point 84 to 85 °C (183 to 185 °F) 86 Boiling point 87 °C (189 °F) 88 Solubility in water 89 mg/mL (20 °C) SMILES 76 InChI InChI=7779 78 Key:8082   (verify)

Test formula 4

Side by side comparison

{{Infobox drug}}

{{Infobox drug/sandbox}}

1 some images Clinical data Pronunciation /njuːˈmoʊniə/ Trade names 25 Other names 72 AHFS/Drugs.com 27 MedlinePlus 29 License data EU EMA: by INN US DailyMed: 32 US FDA: 31 Pregnancy category AU: B3 35 Dependence liability 43 Routes of administration 44 ATC code 5455 (WHO) 56 Legal status Legal status AU: S4 (Prescription only) CA: Schedule IV UK: POM (Prescription only) US: Schedule III UN: Narcotic Schedules II and III EU: Category 2 Precursor In general: ℞ (Prescription only) Pharmacokinetic data Bioavailability 45 Protein binding 46 Metabolism 47 Onset of action 47.5 Elimination half-life 48 Excretion 49 Identifiers IUPAC name 12 CAS Number 5051 52 PubChem CID 57 PubChem SID 58 IUPHAR/BPS 59 DrugBank 60 ChemSpider 6162 UNII 63 KEGG 6566 ChEBI CHEBI:6768 ChEMBL ChEMBL6970 NIAID ChemDB 71 PDB ligand 73 (PDBe, RCSB PDB) Chemical and physical data Formula S28Sb29Se30Si31Sr32Tc33Zn34−1 Molar mass 75 g·mol−1 3D model (JSmol) Interactive image Specific rotation 90 Density 83 g/cm3 Melting point 84 to 85 °C (183 to 185 °F) 86 Boiling point 87 °C (189 °F) 88 Solubility in water 89 mg/mL (20 °C) SMILES 76 InChI InChI=7779 78 Key:8082   (verify)

1 some images Clinical data Pronunciation /njuːˈmoʊniə/ Trade names 25 Other names 72 AHFS/Drugs.com 27 MedlinePlus 29 License data EU EMA: by INN US DailyMed: 32 US FDA: 31 Pregnancy category AU: B3 35 Dependence liability 43 Routes of administration 44 ATC code 5455 (WHO) 56 Legal status Legal status AU: S4 (Prescription only) CA: Schedule IV UK: POM (Prescription only) US: Schedule III UN: Narcotic Schedules II and III EU: Category 2 Precursor In general: ℞ (Prescription only) Pharmacokinetic data Bioavailability 45 Protein binding 46 Metabolism 47 Onset of action 47.5 Elimination half-life 48 Excretion 49 Identifiers IUPAC name 12 CAS Number 5051 52 PubChem CID 57 PubChem SID 58 IUPHAR/BPS 59 DrugBank 60 ChemSpider 6162 UNII 63 KEGG 6566 ChEBI CHEBI:6768 ChEMBL ChEMBL6970 NIAID ChemDB 71 PDB ligand 73 (PDBe, RCSB PDB) Chemical and physical data Formula S28Sb29Se30Si31Sr32Tc33Zn34−1 Molar mass 75 g·mol−1 3D model (JSmol) Interactive image Specific rotation 90 Density 83 g/cm3 Melting point 84 to 85 °C (183 to 185 °F) 86 Boiling point 87 °C (189 °F) 88 Solubility in water 89 mg/mL (20 °C) SMILES 76 InChI InChI=7779 78 Key:8082   (verify)